---
title: Single-cell genomics details the maturation block in BCP-ALL and identifies
  therapeutic vulnerabilities in DUX4-r cases
date: '2024-07-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38968149/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240706182724&v=2.18.0.post9+e462414
source: Blood
description: B cell progenitor acute lymphoblastic leukemia (BCP-ALL) is the most
  common childhood malignancy, driven by multiple genetic alterations that cause maturation
  arrest and accumulation of abnormal progenitor B cells. Current treatment protocols
  with chemotherapy have led to favorable outcomes but are associated with significant
  toxicity and risk of side effects, highlighting the necessity for highly effective,
  less toxic, targeted drugs, even in subtypes with a favorable outcome. Here, we
  ...
disable_comments: true
---
B cell progenitor acute lymphoblastic leukemia (BCP-ALL) is the most common childhood malignancy, driven by multiple genetic alterations that cause maturation arrest and accumulation of abnormal progenitor B cells. Current treatment protocols with chemotherapy have led to favorable outcomes but are associated with significant toxicity and risk of side effects, highlighting the necessity for highly effective, less toxic, targeted drugs, even in subtypes with a favorable outcome. Here, we ...